0001179110-19-004095.txt : 20190320 0001179110-19-004095.hdr.sgml : 20190320 20190320160225 ACCESSION NUMBER: 0001179110-19-004095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190318 FILED AS OF DATE: 20190320 DATE AS OF CHANGE: 20190320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myer Vickesh CENTRAL INDEX KEY: 0001742806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 19694679 MAIL ADDRESS: STREET 1: C/O EDITAS MEDICINE, INC. STREET 2: 11 HURLEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2019-03-18 0 0001650664 Editas Medicine, Inc. EDIT 0001742806 Myer Vickesh C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 Chief Technology Officer Common Stock 2019-03-18 4 M 0 3000 0.65 A 3000 D Common Stock 2019-03-18 4 S 0 3000 24.50 D 0 D Stock Option (right to buy) 0.65 2019-03-18 4 M 0 3000 0 D 2025-04-29 Common Stock 3000 73307 D The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019. /s/ Vickesh Myer 2019-03-20